Bulevirtide monotherapy is safe and well tolerated in patients with chronic hepatitis D (CHD): An integrated safety analysis of 48-week data
Titel:
Bulevirtide monotherapy is safe and well tolerated in patients with chronic hepatitis D (CHD): An integrated safety analysis of 48-week data
Auteur:
Asselah, T. Lampertico, P. Aleman, S. Bourliere, M. Streinu-Cercel, A. Bogomolov, P. Morozov, V. Stepanova, T. Lazar, S. Suri, V. Manuilov, D. Mercier, R.C. Tseng, S. Ye, L. Flaherty, J.F. Osinusi, A. Brunetto, M. Wedemeyer, H.